Måndag 4 Augusti | 10:58:17 Europe / Stockholm

Kalender

Est. tid*
2026-05-04 22:10 Kvartalsrapport 2026-Q1
2026-02-23 N/A Bokslutskommuniké 2025
2025-11-03 22:10 Kvartalsrapport 2025-Q3
2025-08-04 22:10 Kvartalsrapport 2025-Q2
2025-05-28 - Årsstämma
2025-05-02 - Kvartalsrapport 2025-Q1
2025-02-21 - Bokslutskommuniké 2024
2024-10-31 - Kvartalsrapport 2024-Q3
2024-08-02 - Kvartalsrapport 2024-Q2
2024-05-29 - Årsstämma
2024-05-03 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-11-03 - Kvartalsrapport 2023-Q3
2023-08-04 - Kvartalsrapport 2023-Q2
2023-05-24 - Årsstämma
2023-05-05 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-04 - Kvartalsrapport 2022-Q3
2022-08-05 - Kvartalsrapport 2022-Q2
2022-05-26 - Årsstämma
2022-05-06 - Kvartalsrapport 2022-Q1
2022-02-28 - Bokslutskommuniké 2021
2021-11-05 - Kvartalsrapport 2021-Q3
2021-08-09 - Kvartalsrapport 2021-Q2
2021-06-18 - Årsstämma
2021-05-10 - Kvartalsrapport 2021-Q1
2021-02-26 - Bokslutskommuniké 2020
2020-11-06 - Kvartalsrapport 2020-Q3
2020-08-07 - Kvartalsrapport 2020-Q2
2020-06-19 - Årsstämma
2020-05-08 - Kvartalsrapport 2020-Q1
2019-07-31 - Kvartalsrapport 2019-Q2
2019-05-22 - Årsstämma
2019-05-07 - Kvartalsrapport 2019-Q1
2024-12-30 22:30:00

SAN FRANCISCO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference.

iRhythm’s management is scheduled to present on Monday, January 13, 2025, at 4:30 p.m. Pacific Time/7:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com

Media Contact
Kassandra Perry
irhythm@highwirepr.com